Infectious Disease, Surgery, Orthopedics. This company has developed a surgical implant technological platform that serves as an antimicrobial framework indicated to preclude surgical site infections. […]
Imaging, Oncology, Drug Delivery. This company has developed an unprecedented technological platform to enable imaging at the smallest biological scale, the cell. The company’s technology […]
Cardiology, Surgery. Development-stage company that offers a minimally invasive solution for the approximately 850,000 patients at high risk of sudden cardiac arrest. The company’s device […]
Cardiology, Surgery. Company has developed an implantable heart device for treatment of myocardial infarction and other heart diseases where there is a dilation of the […]
Cardiology, Surgery. Company has developed a pain-free, implantable pace-setting device for maintaining a normal cardiac rhythm in patient’s suffering from cardiac arrhythmias where aberrant excitability […]
Aesthetics, Surgery. Early-stage company has developed a novel fat reduction technology utilizing cyroliposis, indicated for body shaping via lessening of unwanted fat tissue in the […]
MicroTransponder is developing a wireless neurostimulation device for the treatment of chronic pain.
Sword Diagnostics of Illinois has developed a “next-generation” system to increase the sensitivity (and therefore accuracy) of diagnostic tests.
There’s one change that women don’t always discuss with their gynecologists.
Jaleva’s Stayzon technology utilizes a specific formulation of resins that is designed to keep medication in place for up to 96 hours and provide extended-release drug delivery to the skin.
Copyright © 2025 | WordPress Theme by MH Themes